Acute life-threatening reversible pulmonary vasoconstrictive reaction to bleomycin chemotherapy demonstrating the clinical application of ePLAR - echocardiographic Pulmonary to Left Atrial Ratio (Letter)
File version
Author(s)
Eliadis, Paul E
Fraser, John F
Little, Samantha G
Scalia, Isabel G
Scalia, Gregory M
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Lung toxicity arising from the chemotherapeutic agent bleomycin typically manifests a spectrum of chronic pulmonary syndromes including interstitial pneumonitis, hypersensitivity pneumonitis, eosinophilic pneumonia and progressive interstitial fibrosis. We report a rare case of acute pulmonary hypertension associated with bleomycin administration, which emphasises the clinical relevance and applicability of the recently described, non-invasive echocardiographic parameter ePLAR (echocardiographic Pulmonary to Left Atrial Ratio).
Journal Title
International Journal of Cardiology
Conference Title
Book Title
Edition
Volume
215
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Cardiovascular medicine and haematology
Health services and systems
Public health
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Pulmonary hypertension
Persistent link to this record
Citation
Waldie, AM; Eliadis, PE; Fraser, JF; Little, SG; Scalia, IG; Scalia, GM, Acute life-threatening reversible pulmonary vasoconstrictive reaction to bleomycin chemotherapy demonstrating the clinical application of ePLAR - echocardiographic Pulmonary to Left Atrial Ratio (Letter), International Journal of Cardiology, 2016, 215, pp. 438-440